Germany: new measures to measure the epidemiological situation starting today |...

New regulations approved by the Parliament (Bundestag) and the State Council (Bundesrat) on criteria for assessing the epidemiological situation and obtaining information on the state of vaccination of employees will be applied in Germany, after they were published in the Official Gazette on Tuesday.

These criteria aim to combat corona in the fall and winter, and based on the new regulations, the main measure for assessing the epidemiological situation will be the number of corona patients in hospitals, replacing the previous focus on the number of infections, which is no longer meaningful in light of vaccination campaigns.

However, “other indicators” will also be taken into account. The states will be allowed to set the maximum values ​​for the severity of the epidemiological situation, and if they are exceeded, more restrictions will be applied to daily life, according to the situation in each state.

In addition, employers will be allowed to ask their employees in day care centers, schools and nursing homes whether they have received a corona vaccination.

More than 62 percent are vaccinated

For his part, the German “Robert Koch” Institute for Disease Control reported on Tuesday that 62.3 percent of the population in Germany (equivalent to about 51.8 million people) had so far received a full two-dose vaccination against Corona. The first of at least an anti-Corona vaccine (equivalent to 55.4 million people).

The German Minister of Health, Jens Young, called again on Twitter today to take advantage of the available vaccination opportunities, in reference to the intensification of the vaccination campaign this week. “Every vaccination will make a difference in the fall and winter,” he wrote.

According to the institute, about 207,000 people have received a third booster dose of an anti-Corona vaccine so far.

As of June 7, anyone in Germany who wants to be vaccinated can get it. Age 12 or older receive a dose of the anti-coronavirus vaccine.

S.M./Y.A. (DPA)

  • Joe Biden receives the Pfizer/Biontech vaccine

    Different nationalities.. Learn about the most famous licensed vaccines around the world

    Biontech/Pfizer Vaccine

    Developed by German Biontech jointly with American Pfizer. Its effectiveness, according to the latest clinical trials, is 95 percent. It is the first vaccine against corona approved by the World Health Organization. It is based on mRNA technology, and is the most widely used vaccine in the Western world, but it has been criticized for the difficulty of storing it, as it needs to minus 70 degrees Celsius to maintain its effectiveness.

  • لقاح موديرنا

    Different nationalities.. Learn about the most famous licensed vaccines around the world

    Moderna

    The second vaccine to be licensed by the European Union after Pfizer/Biontech. Developed by the American company Moderna in cooperation with the US National Institutes of Health for Infectious Diseases. Its effectiveness has reached 95 percent. It adopts almost the same technology (mRNA), but its storage conditions are less stringent and it needs minus 20 degrees. Despite this, the quantities of its distribution in the world remained less than the first vaccine, which may be explained by its price of $ 33 per dose, unlike the second vaccine of $ 20.

  • Sabotonic fertilization V

    Different nationalities.. Learn about the most famous licensed vaccines around the world

    Sputnik V

    It is the first vaccine in the world whose developers announce its effectiveness against Corona, even though it had not yet passed the third stage. It was developed by the Russian State Aesthetic Institute, and its effectiveness reaches 92 percent, according to Russian figures, but with Western scientific hesitation due to the lack of published data on it. It was imported by several countries, including Hungary, Algeria, Serbia and the UAE. It’s easy to transport and cheap ($10) and uses adenovirus (or adenovirus) vector technology.

  • AstraZeneca - vaccine manufacturer

    Different nationalities.. Learn about the most famous licensed vaccines around the world

    AstraZeneca/Oxford

    The second vaccine authorized by the World Health Organization and the third for the European Union. The cheapest vaccines, but also the least effective (70 percent), and many countries questioned its effectiveness against the elderly, as well as against mutated versions. Developed by the British-Swedish company AstraZeneca in cooperation with the University of Oxford. It was imported by several countries after the contribution of the Serum Institute of India to its production. It is easy to transport and store and it also uses glandular conveyor technology.

  • Fertilization of Sinofarm

    Different nationalities.. Learn about the most famous licensed vaccines around the world

    Sinopharm

    Developed by China’s state-owned Sinopharm with Beijing Institute of Biological Products. It was first introduced by the UAE before China licensed it, and then it was imported by several countries, including Morocco, Jordan and Egypt. Its effectiveness rate, according to its manufacturers, reached 79 percent, but the scientific data is not published properly. It uses the inactivated virus injection technique, and the biggest mystery surrounding it is its price, as several reports stated that the dose is not less than $ 30, while others mentioned a lower or higher price.

  • Recep Tayyip Erdogan receives a dose of Coronavac vaccine

    Different nationalities.. Learn about the most famous licensed vaccines around the world

    Coronavac

    It was produced by the Chinese company Sinovac, but licensing it in China took longer. Its effectiveness is controversial, as tests in Brazil showed that it did not exceed 51 percent, but other tests in Turkey, which was among the first to license it, raised the effectiveness to 91 percent. He uses the same technology as the Sinopharma vaccine, and many questions surround him due to the lack of data, especially its price, which has not been reported, although reports have estimated it at ten dollars.

  • Johnson & Johnson Vaccine

    Different nationalities.. Learn about the most famous licensed vaccines around the world

    Johnson & Johnson

    It was developed by the American company “Johnson & Johnson”, and South Africa began using it, although it was not licensed in the United States or Europe, after it was found that it was able to confront the mutated version, contrary to what was shown by first experiences. Its effectiveness reaches 66 percent globally and 72 in America. It is distinguished from others that it is from a single dose, which strengthens its chances of spreading even more. It uses adenovirus vector technology, and is easy to store.

These were the details of the news Germany: new measures to measure the epidemiological situation starting today |... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

Author Information

I am Joshua Kelly and I focus on breaking news stories and ensuring we (“Al-KhaleejToday.NET”) offer timely reporting on some of the most recent stories released through market wires about “Services” sector. I have formerly spent over 3 years as a trader in U.S. Stock Market and is now semi-stepped down. I work on a full time basis for Al-KhaleejToday.NET specializing in quicker moving active shares with a short term view on investment opportunities and trends. Address: 838 Emily Drive Hampton, SC 29924, USA Phone: (+1) 803-887-5567 Email: [email protected]